Niacin/lovastatin

Details

Files

Generic Name:

Niacin/lovastatin

Project Status:

Complete

Therapeutic Area:

Hypercholesterolemia and mixed dyslipidemia

Manufacturer:

Oryx Pharmaceuticals Inc.

Brand Name:

Advicor

Project Line:

Reimbursement Review

Project Number:

SR0042-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Hypercholesterolemia and mixed dyslipidemia

Recommendation Type:

List

Final Recommendation:

April 26, 2006

Recommendation:

(tentative)

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : October 18, 2005